Quest Diagnostics Incorporated

Symbol: DGX

NYSE

138.16

USD

Market price today

  • 18.1274

    P/E Ratio

  • 0.6370

    PEG Ratio

  • 15.35B

    MRK Cap

  • 0.02%

    DIV Yield

Quest Diagnostics Incorporated (DGX) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.33%

Operating Profit Margin

0.14%

Net Profit Margin

0.09%

Return on Assets

0.06%

Return on Equity

0.13%

Return on Capital Employed

0.11%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO:Mr. James E. Davis
Full-time employees:50000
City:Secaucus
Address:500 Plaza Drive
IPO:1996-12-17
CIK:0001022079

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

General Outlook

When we look at how much money they make before expenses, they keep 0.327% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.142%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.091%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.061% return, is a testament to Quest Diagnostics Incorporated's adeptness in optimizing resource deployment. Quest Diagnostics Incorporated's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.133%. Furthermore, the proficiency of Quest Diagnostics Incorporated in capital utilization is underscored by a remarkable 0.113% return on capital employed.

Stock Prices

Quest Diagnostics Incorporated's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $138.41, while its low point bottomed out at $136.47. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Quest Diagnostics Incorporated's stock market.

Liquidity Ratios

Analyzing DGX liquidity ratios reveals its financial health of the firm. The current ratio of 96.95% gauges short-term asset coverage for liabilities. The quick ratio (78.15%) assesses immediate liquidity, while the cash ratio (20.63%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio96.95%
Quick Ratio78.15%
Cash Ratio20.63%

Profitability Ratios

DGX profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 12.05% underscores its earnings before tax deductions. The effective tax rate stands at 22.25%, revealing its tax efficiency. The net income per EBT, 75.60%, and the EBT per EBIT, 84.77%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 14.21%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin12.05%
Effective Tax Rate22.25%
Net Income per EBT75.60%
EBT per EBIT84.77%
EBIT per Revenue14.21%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.97, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding78
Days of Inventory Outstanding11
Operating Cycle62.53
Days of Payables Outstanding72
Cash Conversion Cycle-9
Receivables Turnover7.02
Payables Turnover5.09
Inventory Turnover34.51
Fixed Asset Turnover3.89
Asset Turnover0.67

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 12.00, and free cash flow per share, 8.53, depict cash generation on a per-share basis. The cash per share value, 4.27, showcases liquidity position. A payout ratio of 0.38 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.14, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share12.00
Free Cash Flow per Share8.53
Cash per Share4.27
Payout Ratio0.38
Operating Cash Flow Sales Ratio0.14
Free Cash Flow to Operating Cash Flow Ratio0.71
Cash Flow Coverage Ratio0.27
Short Term Coverage Ratio1.26
Capital Expenditure Coverage Ratio3.46
Dividend Paid and Capex Coverage Ratio1.89
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 34.85%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.76, we discern the balance between debt and equity financing. The long-term debt to capitalization, 37.16%, and total debt to capitalization, 43.05%, ratios shed light on its capital structure. An interest coverage of 7.95 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio34.85%
Debt Equity Ratio0.76
Long Term Debt to Capitalization37.16%
Total Debt to Capitalization43.05%
Interest Coverage7.95
Cash Flow to Debt Ratio0.27
Company Equity Multiplier2.17

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 82.61, provides a glimpse into top-line earnings distributed across each share. Net income per share, 7.63, reflects the portion of profit attributed to each share. The book value per share, 56.31, represents the net asset value distributed per share, while the tangible book value per share, -22.15, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share82.61
Net Income Per Share7.63
Book Value Per Share56.31
Tangible Book Value Per Share-22.15
Shareholders Equity Per Share56.31
Interest Debt Per Share44.80
Capex Per Share-3.64

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -6.38%, indicates top-line expansion, while the gross profit growth, -11.07%, reveals profitability trends. EBIT growth, -11.62%, and operating income growth, -11.62%, offer insights into operational profitability progression. The net income growth, -9.73%, showcases bottom-line expansion, and the EPS growth, -5.80%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-6.38%
Gross Profit Growth-11.07%
EBIT Growth-11.62%
Operating Income Growth-11.62%
Net Income Growth-9.73%
EPS Growth-5.80%
EPS Diluted Growth-5.14%
Weighted Average Shares Growth-3.45%
Weighted Average Shares Diluted Growth-4.24%
Dividends per Share Growth6.63%
Operating Cash Flow Growth-25.96%
Free Cash Flow Growth-34.25%
10-Year Revenue Growth per Share75.71%
5-Year Revenue Growth per Share49.18%
3-Year Revenue Growth per Share17.30%
10-Year Operating CF Growth per Share164.77%
5-Year Operating CF Growth per Share28.71%
3-Year Operating CF Growth per Share-24.10%
10-Year Net Income Growth per Share36.51%
5-Year Net Income Growth per Share40.90%
3-Year Net Income Growth per Share-28.60%
10-Year Dividend per Share Growth per Share130.35%
5-Year Dividend per Share Growth per Share43.34%
3-Year Dividend per Share Growth per Share26.49%
SGA Expenses Growth-12.38%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 20,125,560,000, captures the company's total value, considering both debt and equity. Income quality, 1.50, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 63.46%, indicates the value of non-physical assets, and capex to operating cash flow, -32.08%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value20,125,560,000
Income Quality1.50
Intangibles to Total Assets63.46%
Capex to Operating Cash Flow-32.08%
Capex to Revenue-4.41%
Capex to Depreciation-92.94%
Stock-Based Compensation to Revenue0.83%
Graham Number98.29
Return on Tangible Assets16.67%
Graham Net Net-52.82
Working Capital557,000,000
Tangible Asset Value-2,481,000,000
Net Current Asset Value-5,232,000,000
Invested Capital1
Average Receivables1,202,500,000
Average Payables841,500,000
Average Inventory191,000,000
Days Sales Outstanding48
Days Payables Outstanding79
Days of Inventory On Hand11
ROIC9.44%
ROE0.14%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.38, and the price to book ratio, 2.38, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.65, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 16.21, and price to operating cash flows, 11.51, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.38
Price to Book Ratio2.38
Price to Sales Ratio1.65
Price Cash Flow Ratio11.51
Price Earnings to Growth Ratio0.64
Enterprise Value Multiple5.91
Price Fair Value2.38
Price to Operating Cash Flow Ratio11.51
Price to Free Cash Flows Ratio16.21
Price to Tangible Book Ratio2.45
Enterprise Value to Sales2.18
Enterprise Value Over EBITDA11.24
EV to Operating Cash Flow15.82
Earnings Yield5.53%
Free Cash Flow Yield5.59%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Quest Diagnostics Incorporated (DGX) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 18.127 in 2024.

What is the ticker symbol of Quest Diagnostics Incorporated stock?

The ticker symbol of Quest Diagnostics Incorporated stock is DGX.

What is company IPO date?

IPO date of Quest Diagnostics Incorporated is 1996-12-17.

What is company current share price?

Current share price is 138.160 USD.

What is stock market cap today?

The market cap of stock today is 15348470720.000.

What is PEG ratio in 2024?

The current 0.637 is 0.637 in 2024.

What is the number of employees in 2024?

In 2024 the company has 50000.